In a rebuke of progressive criminal justice policies, California voters on Tuesday rejected a lenient approach by some ...

As the clock ticks down to his inauguration on January 20, DailyMail.com breaks down who President-elect Donald Trump has ...

Merck has signed a licensing agreement worth up to $3.3 billion with Shanghai-based LaNova Medicines to develop, make and ...

Merck & Co. licensed an experimental cancer antibody from a closely held Chinese company in a deal worth $588 million upfront ...

Two new books recounting 33 years of reform insights and proposals by the China Institute for Reform and Development were ...

AstraZeneca's China president has been detained by Chinese authorities amid investigation into illegal importation and ...

In a move to safeguard the company’s dominant position in cancer, Merck said Thursday it will license a new cancer drug from ...

Pfizer (PFE, Financials) announced plans to invest $1 billion in China over the next five years to enhance research and development of innovative drugs. Jean-Christophe Pointeau, president of ...

China's tobacco industry, monopolized by state-owned China Tobacco, realized revenue of about 1.5 trillion yuan ($210 billion ...

as the industry increasingly looks beyond China’s shores with its cutting edge technology in search of growth opportunities. QuantumPharm, a drug discoverer powered by artificial intelligence ...

Pfizer's booth at the China International Import Expo in Shanghai, Nov. 7, 2024. [Photo by Wang Yiming/China.org.cn] Pfizer showcased new treatments for atopic dermatitis, the leading type of ...

The meeting on Friday also stressed efforts to properly implement the policies and work arrangements of the Communist Party of China Central Committee in coping with an aging population and ...